Key Decisions in HIV Care: Choosing ART for Pediatric Patients

In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores key considerations for choosing antiretroviral therapy (ART) for pediatric patients.Listen as she gives perspectives on:Department of Health and Human Services (DHHS) guideline recommendations for infants at risk for perinatal HIV transmissionDHHS guideline–recommended ART regimens for childrenThe ODYSSEY A and B studies evaluating dolutegravir-based ART in children and adolescentsData for the use of the fixed-dose combination bictegravir/emtricitabine/tenofovir alafenamide in children and adolescentsKey ART and management considerations for adolescents and young adults with HIVPresenter:Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVSAssistant Professor of PediatricsDivision of Pediatric Infectious DiseasesPediatric and Adolescent HIV  Children’s Hospital at MontefiorePediatric Hospital of Albert Einstein  College of MedicineBronx, New York  Follow along with the slides at:https://bit.ly/3wMur29Link to full program:https://bit.ly/3fOl0XX  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

There are no comments yet.

Please log in to write the first comment.